Imaging of large vessel vasculitis with 18FDG PET: Illusion or reality? A critical review of the literature data

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 9, 2003, Pages 1305-1313

  Belhocine, Tarik ^a   Blockmans, Daniel ^b   Hustinx, Roland ^c   Vandevivere, Johan ^a   Mortelmans, Luc ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

FDG PET; Giant cell arteritis; Large vessel vasculitides; Takayasu arteritis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AORTA ARCH SYNDROME; ATHEROSCLEROTIC PLAQUE; CANCER DIAGNOSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GIANT CELL ARTERITIS; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; VASCULITIS;

ARTERIES; ARTERIOSCLEROSIS; ARTERITIS; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAKAYASU'S ARTERITIS; TEMPORAL ARTERITIS; TOMOGRAPHY, EMISSION-COMPUTED; VASCULITIS;

EID: 0141559019     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1209-y     Document Type: Review

References (65)

1. Delbeke D. Oncological applications of FDG PET Imaging. J Nucl Med 1999; 40:1706-1715.
2. Pauwels EK, Ribeiro MJ, Stoot JH, McCready VR, Bourguignon M, Mazière B. FDG accumulation and tumor biology. Nucl Med Biol 1998; 25:317-322.
3. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
4. 18F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation. J Nucl Med 2002; 43:658-663.
5. 18F-FDG PET images. J Nucl Med 2002; 43:652-657.
6. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG-PET imaging: physiologic and artifactual fluorodeoxyglucose accumulation. J Nucl Med 1996; 36:441-446.
7. Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F, Ostertag H, Romahn J, van Kaick G. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32:1485-1490.
8. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35:1647-1649.
9. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG PET. Eur J Nucl Med 2000; 27:822-832.
10. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23:739-742.
11. Franzius C, Biermann M, Hulskamp G, Frosch M, Roth J, Sciuk J, Schober O. Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography. Clin Nucl Med 2001; 26:822-832.
12. Lie JT. Illustrated histopathological classification criteria for selected vasculitis syndromes. American Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum 1990; 33:1074-1087.
13. Hunder GG. Classification/diagnostic criteria for GCA/PMR. Clin Exp Rheumatol 2000; 18 (4 Suppl 20):S4-S5.
14. Arend WP, Michel BA, Bloch DA, et al. the American college of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33:1129-1134.
15. Jennette JC, Falk R, Andrassy K, et al. Nomenclature of systemic vasculitis. Proposal of an international conference. Arthritis Rheum 1994; 37:187-192.
16. Gross WL, Trabandt A, Reinhold-Keller E. Diagnosis and evaluation of vasculitis. Rheumatology 2000; 39:245-252.
17. Salvani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 2002; 347: 261-271.
18. 18F-fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 31:191-196.
19. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001; 30:249-256.
20. Lambert M, Hachulla E, Hatron PY, Perez-Cousin M, Beregi JP, Warembourg H, Devulder B. Takayasu's arteritis: vascular investigations and therapeutic management. Experience with 16 patients. Rev Med Interne 1998; 19:878-884.
21. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122:502-507.
22. Liu G, Shupak R, Chiu BK. Aortic dissection in giant-cell arteritis. Semin Arthritis Rheum 1995; 25:160-171.
23. Greene GM, Lain D, Sherwin RM, Wilson JE, McManus BM. Giant cell arteritis of the legs. Clinical isolation of severe disease with gangrene and amputations. Am J Med 1986; 81:727-733.
24. Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83:806-812.
25. Nordborg E, Bengtsson BA. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. BMJ 1989; 299:549-550.
26. Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24:422-431.
27. Kerr GS. Takayasu's arteritis. Rheum Dis Clin North Am 1995; 21:1041-1058.
28. Fauci AS. The vasculitis syndromes. In: Braunwald E, Fauci AS, Kasper DL, Longo DL, Jameson JL, eds. Harrison's principles of internal medicine 2001, 15th edn. New York: McGraw-Hill; 2001:1956-1968.
29. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 1978; 57:27-34.
30. Blockmans D, Maes A, Stroobants S, Nuyts J, Bormans G, Knockaert D, Bobbaers H, Mortelmans L. New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. Rheumatology (Oxf) 1999; 38:444-447.
31. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108:246-249.
32. 18FDG. A propos de trois observations et revue de la littérature. Rev Med Interne 2002; 23:1-8.
33. De Winter F, Petrovic M, Van de Wiele C, Vogelaers D, Afschrift M, Dierckx RA. Imaging of giant cell arteritis: evidence of splenic involvement using FDG positron emission tomography. Clin Nucl Med 2000; 25:633-634.
34. Turlakow A, Yeung HW, Pui J, Macapinlac H, Liebovitz E, Rusch V, Goy A, Larson SM. Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. Arch Intern Med 2001; 161:1003-1007.
35. Hara M, Goodman PC, Leder RA. FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 1999; 23:16-18.
36. Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu aortitis. Eur Radiol 2003; 13:400-405.
37. 18F] FDG PET and MRI. Eur J Nucl Med 2003; 30:730-736.
38. Fahey FH. Positron emission tomography instrumentation. Radiol Clin North Am 2001; 39:919-929.
39. Fayad ZA, Fuster V. Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001; 89:305-316.
40. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A. F-18 FDG uptake in the large arteries. A new observation. Clin Nucl Med 2001; 26:314-319.
41. 18F-FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med 2002; 32:70-76.
42. 18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105:2708-2711.
43. Sakalihasan N, Van Damme H, Gomez P, Rigo P, Lapiere CM, Nusgens B, Limet R. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 2002; 23:431-436
44. 18F-fluorodeoxyglucose (FDG). Nucl Med Commun 2001; 22:747-753.
45. Barron JT, Barany M, Gu L, Parrillo JE. Metabolic fate of glucose in vascular smooth muscle during contraction induced by norepinephrine. J Mol Cell Cardiol 1998; 30:709.
46. Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997; 38:1788-1796.
47. Vallabhajosula S, Machac J, Knesaurek K, et al. Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose (FDG). J Nucl Med 1996; 37:1788-1796.
48. Helft G, Worthley SG, Zhang ZY, Tang C, Rodriguez O, Wei T, Fallon JT, Fayad ZA, Mahac J, Buschsbaum M, Fuster V, Badimon JJ. Non-invasive in vivo imaging of atherosclerotic lesions using fluorine-18 deoxyglucose (18-FDG) PET correlates with macrophage content in a rabbit model [abstract]. Circulation 1999; 100 (Suppl 1):I-311.
49. Mochizuki Y, Fujii H, Yasuda S, Nakahara T, Takahashi W, Ide M, Koide S, Shohtsu A. FDG accumulation in aortic walls. Clin Nucl Med 2001; 26:68-69.
50. Hoogendoorn EH, Oyen WJG, van Dijk APJ, van der Meer JWM. Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose. Clin Microbiol Infect 2003; 9:73-76.
51. Weyand CM, George BB. Giant cell arteritis: new concepts in pathogenesis and implications for management. Am J Ophthalmol 1997; 123:392-395.
52. Hotchi M. Pathological studies on Takayasu arteritis [review]. Heart Vessels Suppl 1992; 7:11-17.
53. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med 1999; 340:115-126.
54. Numano F, Kishi Y, Tanaka A, Ohkawara M, Kakuta T, Kobayashi Y. Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis [review]. Ann N Y Acad Sci 2000; 902:65-76.
55. Numano F. Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 2000; 75 Suppl 1:S1-S8; discussion S17-S19.
56. Kayser M, Younge B, Björnsonn J, Goronzy JJ, Weyland CM. Formation of new vasa vasorum in vasculitis. Am J Pathol 1999; 155:765-774.
57. Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM. Tissue-destructive macrophages in giant cell arteritis. Circ Res 1999; 84:1050-1058.
58. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147:213-225.
59. Disdier P, Pellissier JF, Harle JR. Significance of isolated vasculitis of the vasa vasorum of temporal artery biopsy. J Rheumatol 1994; 21:258-260.
60. Wilcox JN, Scott NA. Potential role of the adventitia in arteritis and atherosclerosis. Int J Cardiol 1996; 54 Suppl 1:21-35.
61. 18F]fluorodeoxyglucose in human monocyte-macrophage in vitro. Eur J Nucl Med 2003; 30:267-273.
62. Zhuang HM, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, Mozley PD, Rossman MD, Albelda SM, Alavi A. Dual time point 18F-FDG imaging for differentiating malignant from inflammatory process. J Nucl Med 2001; 42: 1412-1417.
63. Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Hosokawa M, Tamaki N. Effects of insulin and glucose loading on FDG uptake in experimental malignant tumors and inflammatory lesions. Eur J Nucl Med 2001; 28:730-735.
64. Service RF. New dynamic duo: PET, MRI, joined for the first time. Science 1996; 272:1423.
65. Dizendorf EV, Treyer V, von Schulthess GK, Hany TF. Application of oral contrast media in coregistered positron emission tomography-CT. AJR 2002; 179:477-488.